リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Evaluation of a routine second curettage for hydatidiform mole: a cohort study」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Evaluation of a routine second curettage for hydatidiform mole: a cohort study

Yamamoto, Eiko Nishino, Kimihiro Niimi, Kaoru Watanabe, Eri Oda, Yukari Ino, Kazuhiko Kikkawa, Fumitaka 名古屋大学

2020.06

概要

Objective: The aim of this study was to evaluate routine second curettage for hydatidiform mole (HM) by comparing the characteristics and outcomes of developing gestational trophoblastic neoplasia (GTN).

Study design: This was a cohort study including 173 patients diagnosed with HM between January 2002 and August 2019 who were followed up at Nagoya University Hospital, Japan. After an evacuation, 105 and 68 patients were managed with the routine method (routine group) and elective method (elective group) for a second curettage, respectively. The routine second curettage was performed around 7 days after the first evacuation. Patients in the elective group underwent a second curettage if there was ultrasonographic evidence of molar remnants in the uterine cavity. Socio-clinical factors were retrospectively compared between the routine and elective groups, and between patients showing regression and those who developed GTN.

Results: The incidence of GTN was 15.2% in the routine group and 20.6% in the elective group, and the difference was not significant (P = 0.364). The median GTN risk score was significantly higher in the routine group than in the elective group (P = 0.033). Presence of a complete HM, gestational age, and a pre-treatment human chorionic gonadotropin level of ≥ 200,000 mIU/mL were independent risk factors for GTN in molar patients.

Conclusion: The incidence of GTN was unchanged but the risk score of GTN was higher in the routine group than in the elective group. Routine second curettage may not be necessary, but further study will be needed to confirm this.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1. Lurain JR (2010) Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 203 (6):531-539. doi:10.1016/j.ajog.2010.06.073

2. Yamamoto E, Niimi K, Kiyono T, Yamamoto T, Nishino K, Nakamura K, Kotani T, Kajiyama H, Shibata K, Kikkawa F (2017) Establishment and characterization of cell lines derived from complete hydatidiform mole. Int J Mol Med 40 (3):614-622. doi:10.3892/ijmm.2017.3067

3. Seckl MJ, Sebire NJ, Berkowitz RS (2010) Gestational trophoblastic disease. Lancet 376 (9742):717-729. doi:10.1016/S0140-6736(10)60280-2

4. Kaneki E, Kobayashi H, Hirakawa T, Matsuda T, Kato H, Wake N (2010) Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease. Cancer Sci 101 (7):1717-1721. doi:CAS1602 [pii] 10.1111/j.1349-7006.2010.01602.x

5. Kan M, Yamamoto E, Niimi K, Tamakoshi K, Sekiya Y, Nishino K, Ino K, Kikkawa F (2016) Gestational Trophoblastic Neoplasia and Pregnancy Outcome After Routine Second Curettage for Hydatidiform Mole A Retrospective Observational Study. J Reprod Med 61 (7-8):373-379

6. Kang WD, Choi HS, Kim SM (2012) Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole. Gynecol Oncol 124 (2):250-253. doi:10.1016/j.ygyno.2011.10.035

7. Horn LC, Kowalzik J, Bilek K, Richter CE, Einenkel J (2006) Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles. Eur J Obstet Gynecol Reprod Biol 128 (1- 2):10-14. doi:10.1016/j.ejogrb.2006.01.024

8. Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, Lieberman ES, Berkowitz RS (2006) Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med 51 (11):902-906

9. Sato A, Usui H, Shozu M (2019) Comparison between vacuum aspiration and forceps plus blunt curettage for the evacuation of complete hydatidiform moles. Taiwan J Obstet Gynecol 58 (5):650-655. doi:10.1016/j.tjog.2019.07.012

10. Berkowitz RS, Goldstein DP (2009) Clinical practice. Molar pregnancy. N Engl J Med 360 (16):1639-1645. doi:10.1056/NEJMcp0900696

11. Alazzam M, Young T, Coleman R, Hancock B, Drew D, Wilson P, Tidy J (2011) Predicting gestational trophoblastic neoplasia (GTN): is urine hCG the answer? Gynecol Oncol 122 (3):595-599. doi:10.1016/j.ygyno.2011.05.035

12. Sato S, Yamamoto E, Niimi K, Ino K, Nishino K, Suzuki S, Kotani T, Kajiyama H, Kikkawa F (2019) The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia. Int J Clin Oncol. doi:10.1007/s10147-019- 01540-9

13. Goto S, Ino K, Mitsui T, Kikkawa F, Suzuki T, Nomura S, Mizutani S (2004) Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births. Gynecol Oncol 93 (2):529-535. doi:10.1016/j.ygyno.2004.02.018

14. Lao TT, Lee FH, Yeung SS (1987) Repeat curettage after evacuation of hydatidiform mole. An appraisal. Acta Obstet Gynecol Scand 66 (4):305-307

15. Sasaki S (2003) Management of gestational trophoblastic diseases in Japan--a review. Placenta 24 Suppl A:S28-32

16. Yamamoto E, Trinh TD, Sekiya Y, Tamakoshi K, Nguyen XP, Nishino K, Niimi K, Kotani T, Kajiyama H, Shibata K, Le QT, Kikkawa F (2020) The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: A retrospective observational study. Nagoya J Med Sci 82(2):183-191. doi: 10.18999/nagjms.82.2.183.

17. Golfier F, Raudrant D, Frappart L, Mathian B, Guastalla JP, Trillet-Lenoir V, Vaudoyer F, Hajri T, Schott AM (2007) First epidemiological data from the French Trophoblastic Disease Reference Center. Am J Obstet Gynecol 196 (2):172 e171-175. doi:10.1016/j.ajog.2006.10.867

18. van Trommel NE, Massuger LF, Verheijen RH, Sweep FC, Thomas CM (2005) The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. Gynecol Oncol 99 (1):6-13. doi:10.1016/j.ygyno.2005.06.032

19. Osborne RJ, Filiaci VL, Schink JC, Mannel RS, Behbakht K, Hoffman JS, Spirtos NM, Chan JK, Tidy JA, Miller DS (2016) Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia. Obstet Gynecol 128 (3):535-542. doi:10.1097/AOG.0000000000001554

20. The Japan Society of Obstetrics and Gynecology, the Japanese Pathological Society (1995) The general rules for clinical and pathological management of trophoblastic disease (written in Japanese). Second Edition. Igakushoin, Tokyo.

21. The Japan Society of Obstetrics and Gynecology, the Japanese Pathological Society (2011) The general rules for clinical and pathological management of trophoblastic disease (written in Japanese). Third Edition. Igakushoin, Tokyo.

22. Sumigama S, Itakura A, Yamamoto T, Nagasaka T, Yamamoto E, Ino K, Kikkawa F (2007) Genetically identified complete hydatidiform mole coexisting with a live twin fetus: comparison with conventional diagnosis. Gynecol Obstet Invest 64 (4):228-231. doi:10.1159/000106496

23. Kohorn EI (2001) The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer 11 (1):73-77

24. Niimi K, Yamamoto E, Nishino K, Fujiwara S, Ino K, Kikkawa F (2017) Spontaneous regression of gestational trophoblastic neoplasia. Gynecol Oncol Rep 21:98-100. doi:10.1016/j.gore.2017.07.011

25. Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, Newlands ES (2000) Choriocarcinoma and partial hydatidiform moles. Lancet 356 (9223):36-39. doi:10.1016/S0140-6736(00)02432-6

26. Tidy JA, Gillespie AM, Bright N, Radstone CR, Coleman RE, Hancock BW (2000) Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol 78 (3 Pt 1):309-312. doi:10.1006/gyno.2000.5839

27. Stone M, Bagshawe KD (1979) An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy. Br J Obstet Gynaecol 86 (10):782-792. doi:10.1111/j.1471-0528.1979.tb10694.x

28. Attwood HD, Park WW (1961) Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonw 68:611-617. doi:10.1111/j.1471-0528.1961.tb02778.x

29. Usui H, Kiyokawa T, Qu J, Nishikimi K, Tate S, Mitsuhashi A, Nakatani Y, Shozu M (2016) Comparison Between Pathological Diagnosis and Cytogenetic Diagnosis by Short Tandem Repeat Polymorphism Analysis of Suspected Molar Pregnancies. J Reprod Med 61 (5-6):219-223

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る